Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Vidangadi Kashay
: Group a Vidangadi Kashay 20 ml administered orally twice daily before food.
Intervention3: Vidangadi Kashay: Vidangadi kashay 20ml administer
Sponsors
Dr Gayatri Dattatray Todkar
Eligibility
Inclusion criteria
Inclusion criteria: 1)Age between 20 TO 65 yrs 2)Both genders 3)Signs and symptomps of prediabetes and that of Prameha purvarupawastha 4)Newly diagnosed with prediabetes (IFG between 100-125 and PPBS 140-199) 5)Having HbA1C between 5.7 TO 6.4 %
Exclusion criteria
Exclusion criteria: 1)Prior use of medicine to treat diabetes 2)Pregnant and lactating women 3)Patients having complications like CKD, CA, acute conditions of CHD 4)Patients who are immunocompromised and who are on immunosuppressant medications 5)Those patients who are not ready to comply the trial protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This randomized clinical study is expected to show that Vidangadi Kashaya(Vidanga,Rajni,Yashti,Nagara,Gokshura) is effective in managing Prameha Purvarupa (prediabetes stage). The formulation may help in reducing blood sugar levels (HbA1c, fasting and postprandial BSL) and improving early symptoms like excessive thirst, fatigue, sweating, and burning sensation. When compared with Pioglitazone, Vidangadi Kashaya is anticipated to provide comparable clinical benefits.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Bharat Bansi Kadlaskar
R.A.Podar Govt (Ayu) Medical College, Worli,Mumbai-18
Outcome results
None listed